artesunic acid has been researched along with Bone Loss, Osteoclastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Guo, W; Kong, X; Lin, N; Liu, L; Su, X; Wang, D; Wu, X; Yuan, B; Zhang, Y | 1 |
Huang, L; Lin, XX; Liu, Q; Song, FM; Su, YJ; Wei, CM; Xu, J; Zhao, JM; Zong, SH | 1 |
2 other study(ies) available for artesunic acid and Bone Loss, Osteoclastic
Article | Year |
---|---|
Artesunate attenuates bone erosion in rheumatoid arthritis by suppressing reactive oxygen species via activating p62/Nrf2 signaling.
Topics: Animals; Antioxidants; Antirheumatic Agents; Artesunate; Arthritis, Rheumatoid; Bone Density Conservation Agents; Bone Diseases; Bone Resorption; Heme Oxygenase-1; Joints; Membrane Proteins; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Osteoclasts; Osteogenesis; Reactive Oxygen Species; Signal Transduction | 2021 |
Artesunate inhibits RANKL-induced osteoclastogenesis and bone resorption in vitro and prevents LPS-induced bone loss in vivo.
Topics: Animals; Artemisinins; Artesunate; Bone Resorption; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; I-kappa B Proteins; Lipopolysaccharides; Male; Mice, Inbred C57BL; Osteoclasts; Osteogenesis; Osteolysis; Phosphorylation; Proteolysis; RANK Ligand; Signal Transduction; Time Factors; Transcription Factor RelA; X-Ray Microtomography | 2018 |